Dermapharm Holding SE Profit Margin

Dermapharm Holding SE (DMPHF) currently reports a profit margin of 12.41% as of June 2026. That compares with 9.11% in the prior-year period — up 36.2% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Dermapharm Holding SE's profit margin history and peer comparisons.

Dermapharm Holding SE's profit margin increased from 9.11% to 12.41% — a 36.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dermapharm Holding SE's profit margin of 12.41% is lower than the its sector sector average of 13.16%. That is roughly 5.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Dermapharm Holding SE's current 12.41% should be judged against industry norms (sector average: 13.16%) and against DMPHF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 12.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Dermapharm Holding SE, and consider following DMPHF for alerts when major investors trade the stock.